James P. K. Armstrong

James P. K. Armstrong

Auto-generated profile, based on publicly available information

James P. K. Armstrong

University of Bristol

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 January 2017 in ACS Nano
Verified
Journal Article
Open access
JAJames P. K. Armstrong
James P. K. Armstrong
MHMargaret N. Holme
Margaret N. Holme
MSMolly M. Stevens
Molly M. Stevens
In the past decade, extracellular vesicles (EVs) have emerged as a key cell-free strategy for the treatment of a range of pathologies, including cancer, myocardial infarction, and inflammatory diseases. Indeed, the field is rapidly transitioning from promising in vitro reports toward in vivo animal models and early clinical studies. These investigations exploit the high physicochemical stability and biocompatibility of EVs as well as their innate capacity to communicate with cells via signal transduction and membrane fusion. This review focuses on methods in which EVs can be chemically or biologically modified to broaden, alter, or enhance their therapeutic capability. We examine two broad strategies, which have been used to introduce a wide range of nanoparticles, reporter systems, targeting peptides, pharmaceutics, and functional RNA molecules. First, we explore how EVs can be modified by manipulating their parent cells, either through genetic or metabolic engineering or by introducing exogenous material that is subsequently incorporated into secreted EVs. Second, we consider how EVs can be directly functionalized using strategies such as hydrophobic insertion, covalent surface chemistry, and membrane permeabilization. We discuss the historical context of each specific technology, present prominent examples, and evaluate the complexities, potential pitfalls, and opportunities presented by different re-engineering strategies.

18 August 2020 in Advanced Functional Materials
Verified
Journal Article
Closed access
PDF file
Valeria NeleValeria Nele
Valeria Nele
JWJonathan P. Wojciechowski
Jonathan P. Wojciechowski
JAJames P. K. Armstrong
James P. K. Armstrong
MSMolly M. Stevens
Molly M. Stevens

18 September 2020 in Science Advances
Verified
Journal Article
Open access
PDF file
LOLiliang Ouyang
Liliang Ouyang
JAJames P. K. Armstrong
James P. K. Armstrong
YLYiyang Lin
Yiyang Lin
JWJonathan P. Wojciechowski
Jonathan P. Wojciechowski
CLCharlotte Lee-Reeves
Charlotte Lee-Reeves
MSMolly M. Stevens
Molly M. Stevens
A generalizable strategy enables the expansion of the bioink palette and bioprinting capabilities.

1 August 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
AGAlexander D. Graham
Alexander D. Graham
SOSam N. Olof
Sam N. Olof
MBMadeline J. Burke
Madeline J. Burke
JAJames P. K. Armstrong
James P. K. Armstrong
EMEllina A. Mikhailova
Ellina A. Mikhailova
HBHagan Bayley
Hagan Bayley
Bioprinting is an emerging technique for the fabrication of living tissues that allows cells to be arranged in predetermined three-dimensional (3D) architectures. However, to date, there are limited examples of bioprinted constructs containing multiple cell types patterned at high-resolution. Here we present a low-cost process that employs 3D printing of aqueous droplets containing mammalian cells to produce robust, patterned constructs in oil, which were reproducibly transferred to culture medium. Human embryonic kidney (HEK) cells and ovine mesenchymal stem cells (oMSCs) were printed at tissue-relevant densities (107 cells mL−1) and a high droplet resolution of 1 nL. High-resolution 3D geometries were printed with features of ≤200 μm; these included an arborised cell junction, a diagonal-plane junction and an osteochondral interface. The printed cells showed high viability (90% on average) and HEK cells within the printed structures were shown to proliferate under culture conditions. Significantly, a five-week tissue engineering study demonstrated that printed oMSCs could be differentiated down the chondrogenic lineage to generate cartilage-like structures containing type II collagen.

1 February 2021 in Trends in Biotechnology
Verified
Journal Article
Closed access
CLChunching Li
Chunching Li
LOLiliang Ouyang
Liliang Ouyang
JAJames P.K. Armstrong
James P.K. Armstrong
MSMolly M. Stevens
Molly M. Stevens

7 March 2019 in Advanced Materials
Verified
Journal Article
Open access
PDF file
CLChunching Li
Chunching Li
LOLiliang Ouyang
Liliang Ouyang
IPIsaac J. Pence
Isaac J. Pence
AMAxel C. Moore
Axel C. Moore
YLYiyang Lin
Yiyang Lin
MSMolly M. Stevens
Molly M. Stevens
The controlled fabrication of gradient materials is becoming increasingly important as the next generation of tissue engineering seeks to produce inhomogeneous constructs with physiological complexity. Current strategies for fabricating gradient materials can require highly specialized materials or equipment and cannot be generally applied to the wide range of systems used for tissue engineering. Here, the fundamental physical principle of buoyancy is exploited as a generalized approach for generating materials bearing well‐defined compositional, mechanical, or biochemical gradients. Gradient formation is demonstrated across a range of different materials (e.g., polymers and hydrogels) and cargos (e.g., liposomes, nanoparticles, extracellular vesicles, macromolecules, and small molecules). As well as providing versatility, this buoyancy‐driven gradient approach also offers speed (<1 min) and simplicity (a single injection) using standard laboratory apparatus. Moreover, this technique is readily applied to a major target in complex tissue engineering: the osteochondral interface. A bone morphogenetic protein 2 gradient, presented across a gelatin methacryloyl hydrogel laden with human mesenchymal stem cells, is used to locally stimulate osteogenesis and mineralization in order to produce integrated osteochondral tissue constructs. The versatility and accessibility of this fabrication platform should ensure widespread applicability and provide opportunities to generate other gradient materials or interfacial tissues.